期刊文献+

An integrative Tai Chi program for patients with breast cancer undergoing cancer therapy:study protocol for a randomized controlled feasibility study 被引量:5

An integrative Tai Chi program for patients with breast cancer undergoing cancer therapy:study protocol for a randomized controlled feasibility study
原文传递
导出
摘要 Background: Breast cancer patients experience various side effects during cancer therapy, often resulting in reduced quality of life and poor adherence to treatment. A limited range of proven interventions has been developed to target such side effects. While Tai Chi offers benefits for the health and well-being of breast cancer survivors, the effectiveness of Tai Chi across the treatment continuum has not been evalu- ated. Improved patient education and support has been suggested as a priority for breast cancer care. This pilot study assesses the feasibility of a randomized controlled trial (RCT) to evaluate the effectiveness of "an integrative Tai Chi" (ANITA) program for breast cancer patients undergoing cancer therapy. Methods/design: This is a single-centre, two-arm feasibility RCT. Twenty-four patients with breast cancer who have undergone surgical treatment will be recruited from the Dunedin Hospital (New Zealand) over a 12-month period (from August 2017 to July 2018). Subject to informed consent, patients will be ran- domized to receive standard cancer treatment alone or standard cancer treatment plus the ANITA pro- gram, consisting of peer support, health education, and Tai Chi Ruler exercise. The program runs alongside the patient's adjuvant cancer therapy, which may include chemotherapy, radiation therapy, antibody treatment, and/or antihormonal therapy. Analysis in this study will focus on process evaluation of participant recruitment, retention, treatment fidelity, acceptability of the program, and occurrence of adverse events. Clinical outcomes (i.e., fatigue, sleep quality, anxiety and depression and quality of life) will be assessed at baseline, and at 12 weeks and 24 weeks post-randomization. Discussion: Outcomes from this study will inform the feasibility and methodology for a future fully- powered RCT. Background: Breast cancer patients experience various side effects during cancer therapy, often resulting in reduced quality of life and poor adherence to treatment. A limited range of proven interventions has been developed to target such side effects. While Tai Chi offers benefits for the health and well-being of breast cancer survivors, the effectiveness of Tai Chi across the treatment continuum has not been evalu- ated. Improved patient education and support has been suggested as a priority for breast cancer care. This pilot study assesses the feasibility of a randomized controlled trial (RCT) to evaluate the effectiveness of "an integrative Tai Chi" (ANITA) program for breast cancer patients undergoing cancer therapy. Methods/design: This is a single-centre, two-arm feasibility RCT. Twenty-four patients with breast cancer who have undergone surgical treatment will be recruited from the Dunedin Hospital (New Zealand) over a 12-month period (from August 2017 to July 2018). Subject to informed consent, patients will be ran- domized to receive standard cancer treatment alone or standard cancer treatment plus the ANITA pro- gram, consisting of peer support, health education, and Tai Chi Ruler exercise. The program runs alongside the patient's adjuvant cancer therapy, which may include chemotherapy, radiation therapy, antibody treatment, and/or antihormonal therapy. Analysis in this study will focus on process evaluation of participant recruitment, retention, treatment fidelity, acceptability of the program, and occurrence of adverse events. Clinical outcomes (i.e., fatigue, sleep quality, anxiety and depression and quality of life) will be assessed at baseline, and at 12 weeks and 24 weeks post-randomization. Discussion: Outcomes from this study will inform the feasibility and methodology for a future fully- powered RCT.
出处 《Journal of Integrative Medicine》 CAS CSCD 2018年第2期99-105,共7页 结合医学学报(英文版)
基金 funded by the Breast Cancer Foundation New Zealand support of which is gratefully acknowledged This funding source has no role in this study other than providing funding support LL is funded as the Breast Cancer Foundation New Zealand Belinda Scott Clinical Fellowship 2017
关键词 Tai Chi Breast cancer Feasibility study Randomized controlled trial Peer support Health education Tai Chi Breast cancer Feasibility study Randomized controlled trial Peer support Health education
  • 相关文献

参考文献1

二级参考文献77

  • 1DeSantis C, Ma J, Bryan L, et al. Breast cancer statistics,2013. CA CancerJClin 2014; 64: 52-62.
  • 2Eppenberger-Castori S, Moore DH Jr, Thor AD, et al. Age-associated biomarker profiles of human breast cancer. Int J Biochem Cell Bio12002 ; 34:1318-1330.
  • 3Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006; 295: 2492-2502.
  • 4de Kruijf EM, Bastiaannet E, Ruberfft F, et al. Comparison of frequencies and prognostic effect of molecular subtypes be- tween young and elderly breast cancer patients. Mol Oncol 2014; 8: 1014-1025.
  • 5Ebner F, van Ewijk R, W6ckel A, et al. Tumor biology in older breast cancer patients--what is the impact on survival stratified for guideline adherence? A retrospective multi-cen- tre cohort study of 5378 patients. Breast 2015; 24: 256-262.
  • 6Rosso S, Gondos A, Zanetti R, et al. Up-to-date estimates of breast cancer survival for the years 2000-2004 in 11 European countries: the role of screening and a comparison with data from the United States. Eur J Cancer 2010; 46:3351-3357.
  • 7Angarita FA, Chesney T, Elser C, et al. Treatment patterns of elderly breast cancer patients at two Canadian cancer centres. Eur J Surg Onco12015; 41: 625-634.
  • 8Muss HB, Woolf S, Berry D, et al. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 2005; 293: 1073-1081.
  • 9Muss HB, Berry DA, Cinincione CT, et al. Adjuvant che- motherapy in older women with early-stage breast cancer. N EnglJMed 2009; 360: 2055-2065.
  • 10Sawaki M, Tokudome N, Mizuno T, et al. Evaluation of tras- tuzumab without chemotherapy as a post-operative adjuvant therapy in HER2-positive elderly breast cancer patients: ran- domized controlled trial [RESPECT (N-SAS BC07)]. Jpn J Clin Onco12011; 41: 709-712.

共引文献9

同被引文献23

引证文献5

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部